*** ems the next uni (unitract)

Issuer Name: EASTLAND MEDICAL SYSTEMS LTD
Description: ORDINARY FULLY PAID

Security Last +/- Bid Ask Volume Value Basis R Status High Low Ex
EMS 30 1.5 29.5 30 2173760 654031 31.5 27.5 ASX
High Low Volume Value
Week Rolling 34 19.5 13624299 4129287
Month Rolling 34 18 14936719 4391172
Year Rolling 34 5.7 33051038 8576369
Prev. Year 28 5.7 13293531 2278370
First Listed Date : 24-Jan-2002 Paid Up Value : 0.00
Last Listed Date : Par Value : 0.00
Suspension Date : Asset Backing : 1.00
Currency : AUD Price / NTA : 30.00
Shares On Issue : 23676121 EPS : -1.18
Market Cap ($) : 6747694 PE Ratio : -25.42
Sub-Industry : Health Care Equipment & Services - 3510 Yearly Dividend : 0
Div Yield (%) : 0.00

EASTLAND MEDICAL SYSTEMS LTD 2003-04-15 ASX-SIGNAL-G

HOMEX - Perth

+++++++++++++++++++++++++
Eastland Medical Systems Ltd is pleased to announce that it has now
completed the development of their patented "Reversyringe" Device.

"Reversyringe" is the only true automatic retract syringe in the
world that retracts and self destructs during operation of any
procedure without the need for healthcare workers to activate the
retraction. "Reversyringe" achieves its automatic retraction and self
destruction without the need for the use of springs or activation by
the user.

The use of springs in retraction of needles in retractable syringes
has been a World wide problem in the mass production by automated
assembly and is still a major problem adding cost and downtime due to
the tangling of springs.

"Reversyinge" has granted patents and its targeted market is the
pre-filled syringe market incorporating mass immunisation programs
and the specialist self administration markets.

"Reversyringe", like all of Eastland safe products, can be rendered
safe at any time during a procedure, an essential function of a truly
safe device. This product has been developed to compete with other
more complicated devices within the retractable syringe market.

The development of the P A P needle technology, developed at the
Portland facility, now provides Eastland's full range of injectable
devices with considerable advantages over its competitors, not only
in design and function but also cost. The cost of needles will now be
reduced by half when Eastland introduce the manufacturing of its own
needles at Portland.

The patents owned by Eastland Medical Systems - including its unique
Clip-On syringe converter for the prevention of needlestick injuries
- have been acquired and developed to respond to the international
demands of the health industry.

Marina Valmadre Don O'Sullivan, CEO AND MANAGING
Oak Ridge Communication Group DIRECTOR
(08) 9481-4566 or 0408 98 28 18 Eastland Medical Systems Ltd
or (08) 9481-1844
Email; [email protected]
Website; www.eastlandmedical.com